Angioblast Systems, Inc.

275 Madison Ave 4th floor

New York
United States
www.angioblast.com


Financial year end: December

Company Overview

Angioblast Systems, Inc. is a US based biotechnology company. The company is engaged in development and commercialization of therapeutic products for the treatment of cardiovascular diseases. It provides various products which includes adult stem cells, protein therapeutics, gene silencing, small molecule peptides and antibodies, cytokines and antigen-receptor inhibitors, and DNAzymes. It also offers the MPC products for heart failure, heart attacks, peripheral artery diseases, and wound ulcers. The company has a strategic alliance with Mesoblast Limited. The company forms the relationships with diverse corporate partners to enable rapid penetration in each market by product and geography. The company is headquartered at New York, the US.

Buy the Full Version

The following reports are available on Angioblast Systems, Inc.:

Angioblast Systems, Inc. - Medical Equipment Product Pipeline Analysis

Price:$750.00